| COVID-19 severity and outcomes in patients with cancer: a matched cohort study G Brar, LC Pinheiro, M Shusterman, B Swed, E Reshetnyak, O Soroka, ... Journal of Clinical Oncology 38 (33), 3914, 2020 | 154 | 2020 |
| IMiDs new and old S Yamshon, J Ruan Current Hematologic Malignancy Reports 14, 414-425, 2019 | 29 | 2019 |
| Initial treatment with lenalidomide plus rituximab for mantle cell lymphoma (MCL): 7-year analysis from a multi-center phase II study S Yamshon, P Martin, B Shah, SJ Schuster, PJ Christos, A Rodriguez, ... Blood 136, 45-46, 2020 | 15 | 2020 |
| Analysis of outcomes and predictors of response in patients with relapsed mantle cell lymphoma treated with brexucabtagene autoleucel JT Romancik, S Goyal, JN Gerson, HJ Ballard, Y Sawalha, DA Bond, ... Blood 138, 1756, 2021 | 14 | 2021 |
| Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma treated with lenalidomide: a systematic review and meta-analysis S Yamshon, PJ Christos, M Demetres, H Hammad, JP Leonard, J Ruan Blood Advances 2 (12), 1429-1438, 2018 | 14 | 2018 |
| Epigenetic, metabolic, and immune crosstalk in germinal-center-derived B-cell lymphomas: unveiling new vulnerabilities for rational combination therapies I Serganova, S Chakraborty, S Yamshon, Y Isshiki, R Bucktrout, A Melnick, ... Frontiers in Cell and Developmental Biology 9, 805195, 2022 | 10 | 2022 |
| Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma S Yamshon, GZ Chen, C Gribbin, P Christos, B Shah, SJ Schuster, ... Blood advances 7 (21), 6579-6588, 2023 | 5 | 2023 |
| Long Covid in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection O Fankuchen, J Lau, M Rajan, B Swed, P Martin, M Hidalgo, S Yamshon, ... American journal of clinical oncology 46 (7), 300-305, 2023 | 2 | 2023 |
| Screening chest CT prior to allogenic hematopoietic stem cell transplantation M Alhomoud, N Chokr, A Gomez-Arteaga, Z Chen, JG Escalon, ... Transplantation and Cellular Therapy 29 (5), 326. e1-326. e10, 2023 | 2 | 2023 |
| Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma S Yamshon, P Martin Clinical Advances in Hematology & Oncology: H&O 19 (6), 376-382, 2021 | 2 | 2021 |
| Venous thromboembolism in patients with B-cell non-Hodgkin lymphoma (NHL) treated with lenalidomide S Yamshon, M Demetres, H Hammad, PJ Christos, JP Leonard, J Ruan Blood 130, 221, 2017 | 2 | 2017 |
| Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis S Yamshon, C Gribbin, Z Chen, M Demetres, M Pasciolla, M Alhomoud, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | 1 | 2024 |
| Low Dose Total Body Irradiation Improves CD19 CAR-T Expansion, Persistence, and Trafficking, Leading to Enhanced Efficacy in Large B-Cell Lymphoma M Alhomoud, M Foley, M Sugita, T Yamazaki, L Martinez, S Yamshon, ... Blood 142, 1016, 2023 | 1 | 2023 |
| An update on options of therapy for aggressive mantle cell lymphoma J Ruan, S Yamshon, K Van Besien, P Martin Leukemia & Lymphoma 61 (9), 2036-2049, 2020 | 1 | 2020 |
| Non-Destructive Post-Transplant Lymphoproliferative Disorder Shows Distinct Clinical Features with HHV-6 Reactivation in a Subset S Yamshon, MD Cantu, E Cesarman, SC Rutherford, A Chadburn, ... Blood 134, 2792, 2019 | 1 | 2019 |
| Correlative Analysis and Clinical Update Of a Phase II Study Using Lenalidomide and Rituximab In Patients With Indolent Non-Hodgkin Lymphoma S Yamshon, L Qi, C Yu, XD Li, R O'Donnell, J Tuscano Blood 122 (21), 249-249, 2013 | 1 | 2013 |
| Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma M Mejia Saldarriaga, D Pan, C Unkenholz, TH Mouhieddine, ... Blood Advances, bloodadvances. 2023012470, 2024 | | 2024 |
| Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis S Yamshon, C Gribbin, M Alhomoud, N Chokr, Z Chen, M Demetres, ... Clinical Lymphoma Myeloma and Leukemia, 2024 | | 2024 |
| Safety and Efficacy of Bridging Radiation Therapy in the Context of CD19 CART Therapy for Non-Hodgkin Lymphoma: Systematic Review and Meta-Analysis M Alhomoud, R Ibrahim, Z Chen, J Martinet, M Foley, A Gomez-Arteaga, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
| Axicabtagene Ciloleucel for Lymphoma in Patients Aged 75 and Older: A Retrospective Cohort Study N Easwar, JA Fein, MS Pasciolla, R Abramova, TB Shore, S Yamshon Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | | 2024 |
